Abstract Biomedical waste management is an integral part of health care as being the mainstay of hospital cleanliness, hygiene, and maintenance activities. Medical care is crucial for human health but mismanagement of biomedical waste harms the flora and fauna of ecosystem on earth, and badly influences the human health. Due to their stability, biomedical wastes are not eliminated by the solid or sewage treatment plants, and get bioaccumulated in environment, and eventually get to population through various means. They are harmful due to their potential carcinogenicity, genotoxicity, mutagenicity, and other toxicities. Current disposal techniques employed in disposing biomedical wastes are sewage/drains, incineration, and landfills. These practices are normally costly and might transform pollutants from one toxic form to another. Whereas bioremediation is an inexpensive method of employing naturally occurring microorganisms or plants to detoxify man-made pollutants to harmless products that make soil fertile as well in the process. Researchers have also evolved genetically engineered microbes to remediate environmental pollutants including radionuclides. Phytoremediation is also a type of sustainable methods, which is reasonable and competent in handling heavy metals and radioactive waste generated from hospitals. In this article, we have summarized rational applications of bioremediation techniques of using effective microorganisms and plants in enhanced removal of several recalcitrant pollutants including biomedical waste. Our review highlights the challenges and future perspectives to bioremediate non-biodegradable and potentially toxic hospital wastes.

Emergence of drug-resistant strains has demanded for alternative means of combating fungal infections. Oils of Carum copticum and Thymus vulgaris have long been used in ethnomedicine for ailments of various fungal infections. Since their activity has not been reported in particular against drug-resistant fungi, this study was aimed to evaluate the effects of oils of C. copticum and T. vulgaris on the growth and virulence of drug-resistant strains of Aspergillus spp. and Trichophyton rubrum. The gas chromatography-mass spectrometry analysis revealed thymol constituting 44.71% and 22.82% of T. vulgaris and C. copticum, respectively. Inhibition of mycelial growth by essential oils was recorded in the order of thymol > T. vulgaris > C. copticum against the tested strains. RBC lysis assay showed no tested oils to be toxic even up to concentration two folds higher than their respective MFCs. Thymol exhibited highest synergy in combination with fluconazole against Aspergillus fumigatus MTCC2550 (FICI value 0.187) and T. rubrum IOA9 (0.156) as determined by checkerboard method. Thymol and T. vulgaris essential oil were equally effective against both the macro and arthroconidia growth (MIC 72 µg/mL). A > 80% reduction in elastase activity was recorded for A. fumigatus MTCC2550 by C. copticum, T. vulgaris oils and thymol. The effectiveness of these oils against arthroconidia and synergistic interaction of thymol and T. vulgaris with fluconazole can be exploited to potentiate the antifungal effects of fluconazole against drug-resistant strains of T. rubrum and Aspergillus spp.